This trial studies how well a PET scan using fluciclovine helps to detect prostate cancer and if site-directed treatment to abnormalities found on the scan works well for treating patients with prostate cancer.
1 Primary · 6 Secondary · Reporting Duration: Up to 7 years
100 Total Participants · 3 Treatment Groups
Primary Treatment: Radiation Therapy · No Placebo Group · Phase 2
Age 18+ · Male Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: